Digital Genome Market Overview by Top Players Illumina, PerkinElmer, Thermo Fisher Scientific

Digital genome is powerful tool to analyze personal genome patterns in digital way to precisely detect any gene alteration. It is majorly used in molecular diagnosis of wide variety of disease such as cancer, infectious disease, organ transplant, and pre-natal health monitoring. Increasing incidence of infectious diseases among the global population and increasing adoption of personalized medicines for the disease treatments using patient’s genetic information are expected to aid in offering targeted treatment. This in turn is expected to create lucrative growth opportunities for the digital genome market in the near future.

Engagement of various key players and government regulatory organizations to launch digital genome-based products and services to conduct extensive research and development (R&D) in development of personalized medicines for cancer, diabetes, and other infectious diseases are expected to drive growth of the global digital genome market. Furthermore, integration of Artificial Intelligence (AI) to efficiently analyze the complex genome data and thereby, easy utilization of these genomic data by heathcare professionals, clinicians, and researchers is expected to increase adoption of digital genome technologies over the forecast period.

For instance, the Genomics R&D Initiative (GRDI) based in Canada cooperates with other federal science departments and agencies such as Agriculture and Agri-Food Canada, the Canadian Food Inspection Agency, Environment and Climate Change Canada, the National Research Council of Canada, Natural Resources Canada, among others to carryout vital genomic research. According to the Genomics R&D Initiative (GRDI) June 2017: GRDI receives around US$ 20 million annually from Government of Canada (GoC) to conduct this research.

Key features of the study:

This report provides in-depth analysis of digital genome market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2018, as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players

It profiles key players in the global digital genome market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies.
Key companies covered as a part of this study include, Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC, Amazon.com, Inc., Deep Genomics, Deep Genomics, Deep Genomics, Desktop Genetics Ltd., and Ancestry.com LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type upgradation, market expansion, and marketing tactics.

The global digital genome market report caters to various stakeholders in this industry including investors, researchers, digital genome organizations, new entrants, and financial analysts.

Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the digital genome market.

Buy This Complete A Business Report:  https://www.coherentmarketinsights.com/insight/buy-now/136 

Company Profiles:
Illumina, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
PerkinElmer, Inc.
Pacific Biosciences of California, Inc.
Thermo Fisher Scientific Inc.
Oxford Nanopore Technologies Limited
Nanostring Technologies, Inc.
IBM Corporation
Google LLC
Amazon.com, Inc.
Deep Genomics
GenomeMe
23andMe
Desktop Genetics Ltd.
Ancestry.com LLC

Detailed Segmentation:

By Product Type:
Sequencer & Analyzers
Reagents & Kits
Sequencing & Analysis Software

By Application:
Clinical
Reproductive Health
Oncology
Others
Forensics
Drug Discovery and Development
Other Applications

By End User:
Hospitals
Diagnostic Centers
Research Institutes
Biotechnology and Pharmaceutical Companies
Others

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.